1 year return (CAGR)
11.39%
TG Therapeutics Inc Exchange (NASDAQ, USD)
TGTX
53.04
+5.87 (+16.26%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
11.06%
5 year return (CAGR)
-0.49%
10 year return (CAGR)
15.92%
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
6.70B
Price/Sales
10.88
Ent value
7.04B
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
14.99
PEG
-
Forward P/E
17.44
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 36.25 |
| Daily high | 42.09 |
| Daily low | 36.25 |
| Daily Volume | 6.10M |
| All-time high | 142382.81 |
| 1y analyst estimate | 69.71 |
| Beta | 1.67 |
| EPS (TTM) | 2.81 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| TGTX | S&P500 | |
| Current price drop from All-time high | -99.96% | -2.63% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 29 Dec 2011 | 9 Mar 2009 |
| Avg drop from high | -91.29% | -10.69% |
| Avg time to new high | 398 days | 12 days |
| Max time to new high | 6753 days | 1805 days |
News
